There are no items in your shopping cart
MF C21H23F3N6O2MW 448.44
Potent, selective, and orally active anti-fibrotic JNK inhibitor (IC50 values 61 nM, 7 nM, 6 nM, 480 nM, and 3400 nM for JNK1, JNK2, JNK3, ERK1, and p38α, respectively) for treatment of idiopathic pulmonary fibrosis (IPF).KEYWORDS: CC-930 | supplier | JNK inhibitor | Tanzisertib | CC930 | CAS [899805-25-5] | MAPK | c-Jun N-terminal kinase | JNK | JNK1 | JNK2 | JNK3 | p38α | idiopathic pulmonary fibrosis | IPF | TGF
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
Download the Axon Ligands™ catalogue Spring 2017 Edition
* Required Fields